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ERISA Health Plan Denials
Federal policymakers face growing pressure from
several quarters to bolster consumer protections avail-
able to the 125 million people in private-sector em-
ployee health plans. Spurred by consumer reaction to
some managed care practices, provider attempts to
improve their bargaining position with purchasers, and
a flurry of state legislation that might conflict with
federal law, Congress and the executive branch are
considering a continuum of controversial proposals.
Some of these would alter or establish internal health
plan grievance procedures, impose external review of
plan decisions, and provide greater access to court
remedies for plan members. While there is great varia-
tion in the reform proposals and disagreement about
how much consumers might be hurt by the current
limitations of their appeal and legal options, a pivotal
issue is whether patients disputing health plan denials
of medical treatment or coverage should have access to
independent, external review of plan decisions.
This Forum session will explore the experience of two
existing models for reviewing managed care plan deci-
sions, one used by the Medicare program and another by
the state of Florida. Taking into account what other states
have done, the meeting also will explore key issues facing
federal policymakers currently attempting to reconstruct
and integrate the elements of the grievance, appeals, and
legal processes available to consumers under the Em-
ployee Retirement Income Security Act of 1974 (ERISA),
which governs about 2.5 million private-sector employee
health plans. (As touched on later, ERISA bars states
from regulating private-sector employee health plans but
allows them to regulate many functions performed by
insurers and managed care organizations serving ERISA
plans.) The discussion also will consider how to enhance
consumer protections without blunting plan sponsors’
ability to contain costs.
PROBLEMS
The protections available to consumers involved in
disputes with health plans can be viewed as a contin-
uum: first involving internal review, then external
review, and finally judicial review. Advocates of
increased consumer protections1 argue that current laws
and regulations governing private-sector plans leave
people exposed to potential physical and financial harm
resulting from plan denial of coverage and treatments,
often on grounds that the treatments are not medically
necessary or are experimental. Groups representing
employers and health plans generally defend the flexi-
bility that ERISA gives them to administer benefit plans
in a nationally uniform and cost-effective manner and
argue that the law already offers consumers adequate
tools to address plan denials of treatments or payment.
ERISA currently has no requirement for external,
independent review of a plan’s denial of a benefit,
including medical treatment denied under a utilization
review program. A plan participant appealing a denial
must go through an internal grievance process before
being able to access the courts. The law states that
every ERISA plan shall “afford a reasonable opportu-
nity to any participant whose claim for benefits has
been denied for a full and fair review by the appropriate
named fiduciary of the decision denying the claim.”2
Under regulations further defining ERISA’s claim
procedure, a plan has 90 days to make a determination
on a request for a plan benefit by a participant.3 An
extension of up to 90 more days is available for “special
circumstances.” The plan may establish a reasonable
time period of no less than 60 days in which a claimant
may request an appeal. According to the regulations, an
appeal decision is supposed to be made promptly—not
later than 60 days after the plan’s receipt of the request
for review or, if an extension is required due to special
circumstances, not later than 120 days after receipt of a
request for review. Despite the length of time allowed
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for a claim decision under the regulations, most em-
ployer plans process claims far more expeditiously,
according to employer representatives. A denial must be
in writing and must detail the reason the claim was
denied, including references to the provision of the plan
supporting the denial.
Once an ERISA plan’s internal grievance and
appeals process is exhausted, legal remedies available
to consumers in court are narrow compared to state law
remedies. The law permits participants to seek recovery
of benefits in a federal court but does not allow them to
redress unreasonable delay, fraud, malice, emotional
distress, or other harms.4 Participants cannot recover
actual out-of-pocket costs, such as additional medical
expenses or lost wages incurred as a consequence of
denied coverage. Perhaps most significant, given the
proliferation of preauthorization of medical care as a
common feature of health plans, ERISA provides no
remedy for injuries caused by denials of treatment or
payment, other than eventual coverage of a benefit
promised in the plan documents.
Federal courts of appeals are divided on the issue of
whether ERISA preempts state lawsuits against man-
aged care plans challenging the quality of the medical
care provided by their contracting physicians.5 A
growing number of federal courts hold that ERISA does
not prohibit patients from suing a managed care organi-
zation for vicarious liability of physicians who are its
agents. (Not all federal circuit courts have addressed the
question of whether a health maintenance organization
[HMO] can be vicariously liable for medical malprac-
tice, but a majority of the circuits that have considered
the issue do permit these suits. A minority of circuits
refuse to recognize this concept.)6 Thus, under the
current state of the law, if a court concludes that a
person was injured by a substandard medical decision,
a plaintiff injured by a plan denial may stand some
chance of recovering damages, but if the case is charac-
terized as a coverage decision, ERISA confines plain-
tiffs to recovering benefits per se. In Corcoran v.
United Healthcare, Inc.,7 for example, the court charac-
terized a plan’s decision to deny hospital care to a
woman with a problem pregnancy (and instead to
supply several hours of daily home nursing care) to be
a determination about covered plan benefits. When the
fetus died, allegedly as a result of the mother’s not
being in a hospital setting, she could not recover
damages for this loss.
Many argue that the regulations governing ERISA’s
claims process, which were promulgated in 1977, are
antiquated as far as health plans are concerned. When
the regulation was developed, disputes over benefits
almost always involved payment and occurred after
services had been rendered. Managed care practices
such as preauthorization of medical services were not
widely used. Today, many disputes involve denial of
medical care itself. The length of the grievance process
alone may create a barrier for participants needing
immediate medical attention who are involved in
disputes with plans over benefit denials. Many of the
suits that go to court are brought by members of a
deceased patient’s family. A hypothetical “worst-case
scenario” illustrates the problem from the participant’s
point of view: A patient needs an expensive surgery. An
insurer undergoing solvency problems denies the
request on the grounds of medical necessity in order to
delay incurring a major expense. The patient dies by the
time the case goes to court. The court rules that the
patient was entitled to the surgery under the contract,
but the patient is no longer alive. The family has no way
to collect damages both to compensate for wrongful
death and to deter plans from making a similar decision
in the future.
While declining to make recommendations on
whether to expand ERISA plan participants’ legal
remedies, the President’s Advisory Commission on
Consumer Protection and Quality in the Health Care
Industry recently concluded that all consumers should
have a right to a fair and efficient process to resolve
disputes with health plans, providers, and institutions
serving them, including a rigorous system of internal
review and an independent system of external review.8
The commission concluded that both the internal and
external appeals systems should resolve disputes in a
timely manner, with decisions involving emergency or
urgent care being given expedited consideration consis-
tent with time frames that the Medicare program
requires of its risk contractors. It also recommended that
external reviews be conducted by appropriately creden-
tialed professionals who were not involved in the initial
decision and have no conflict of interest.
DEPARTMENT OF LABOR POSITION
The U.S. Department of Labor (DOL), which
administers ERISA, is considering revamping its claims
procedure requirements. In a request for information
concerning proposed changes, the department noted
that the current regulation was drafted in response to
concern about plan practices prior to the passage of
ERISA, particularly with respect to participants’ lack of
information about claims procedures generally. The
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current regulation makes no distinction between pen-
sion and health plans. The department also noted that
many changes have since occurred in the health care
marketplace, in health policy, and in business communi-
cations. In broaching its concern about “timely resolu-
tion of requests for medical treatment from group health
plans,” the labor department also pointed to Medicare’s
expedited review process as a possible model.9 While
considering changes to ERISA plans’ internal grievance
process requirements, labor department officials have
publicly stated that they have no jurisdiction to require
external review of plan decisions. Such a requirement
would require an act of Congress.
In May 19 testimony before the Senate Committee
on Labor and Human Resources, Olena Berg, assistant
secretary of DOL’s Pension and Welfare Benefits
Administration, said that the department intended to
publish a proposed claims procedure regulation within
60 days. Comments received by the department indi-
cated consensus that the time frames need to be shorter.
According to Berg, DOL considers it within its regula-
tory authority to do the following:
 Make clear that a benefit denial includes adverse
determinations under a utilization review program,
denials of access to (or reimbursement for) medical
services, denials of access to (or reimbursement for)
specialists, and any decision that a service, treatment,
drug, or other benefit is not medically necessary.
 Require that benefit claims and appeals involving
urgent care be processed with a time frame appropri-
ate to the medical emergency, but no more than 72
hours.
 Require, with respect to non-urgent claims, that the
plan either decide the claim or notify the claimant
that the claim is incomplete within 15 days of
receiving the claim (claimants then would have at
least 45 days to provide any information to complete
the claim and, once complete, the claim would have
to be decided within 15 days).
 Require that, if a non-urgent claim is denied, the
claimant be afforded at least 180 days to appeal and
that a decision on the appealed claim be made
within 30 days of receipt of the appeal by the plan.
 Require consultation with qualified medical profes-
sionals in deciding appeals involving medical
judgments.
 Require that appealed claims be reviewed de novo
(that is, review may not be limited to information
and documents considered in the initial claims
denial) and be decided by a party other than the one
who made the original claim determination.
However, according to Berg and other DOL officials,
bolstering ERISA’s internal claims procedure is not
enough to adequately protect consumers. DOL Associ-
ate Solicitor for Plan Benefits Security Marc I. Machiz
recently testified that, while the department can promul-
gate a more protective claim processing regulation, it
cannot assure compliance with that regulation if no cost
is imposed on plans for failing to comply. According to
Machiz:
Under current law, a plan fiduciary who fails to assure
compliance with the time limits or notice provisions
of our current regulation, or any future regulation, is
not accountable for that failure. At best, an aggrieved
participant may treat the claim as denied and proceed
to court, still without the benefit of a clear explanation
of his denial or access to pertinent documents that
might help him evaluate or prove his claim. Perhaps
after wasting critically important weeks attempting to
avail himself of the plan’s claims procedures, he may
find himself in court with his health already injured
and his need for treatment mooted by the progress of
his illness, or even death. If the plan’s delay in provid-
ing a decision, or recalcitrance in providing critical
information causes injury, the participant has no
recourse, and the responsible fiduciary suffers no
consequences.10
Because of financial incentives to delay providing
costly medical treatment and the labor department’s
limited ability to strengthen consumer protection by
revamping the internal grievance process, the depart-
ment is advocating that Congress increase the legal
remedies available to ERISA plan participants injured
by denials of medical care. In addition, the department
is urging Congress to enact legislation providing
independent, external review of plan decisions.
Under its authority to protect employee welfare
plans, DOL can investigate complaints regarding health
plan conduct and file suit to impose fines or an injunc-
tion. ERISA, however, does not explicitly empower
DOL to pursue court cases or administrative remedies
on behalf of individuals disputing health plan benefit
denials.11 
BILLS BEFORE CONGRESS
Many of the consumer protection bills before Con-
gress would establish the right to an external appeal for
ERISA plan participants while further defining internal
appeal procedures. These include H.R. 3605/S. 1890
(sponsored by Rep. John D. Dingell [D-Mich.] and
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Sens. Edward M. Kennedy [D-Mass.] and Tom Daschle
[D-S.D.]); S. 1712 (Sens. James M. Jeffords [R-Vt.]
and Joseph I. Lieberman [D-Conn.]); and a recent
discussion draft of a bill sponsored by Rep. Charlie
Norwood (R-Ga). (An earlier version, sponsored by
Norwood and Sen. Alfonso M .D’Amato [R-N.Y.],   is
H.R. 1415/S. 644. Norwood later introduced H.R. 2960,
in order to limit circumstances under which employers
would be exposed to liability under state tort law.) The
bills generally amend ERISA and the Public Health
Service Act to apply similar standards to both ERISA
plans and state-licensed insurers and HMOs. All but the
Jeffords bill would amplify the legal remedies available
to ERISA plan participants. (Jeffords’s staff have
characterized his bill’s external review feature as a
substitute for increased court remedies.) All three of the
above-mentioned bills feature expedited review of plan
denials in the internal grievance process, but only the
Dingell and Norwood bills provide for expedited review
at the external appeals stage.
Generally speaking, the bills before Congress are
being pushed by provider and consumer interests, while
most employer, insurer, and managed care plan interest
groups oppose laws that would limit their ability to
contract with providers, constrain their ability to orga-
nize provider networks and design managed care
products, increase regulatory requirements for con-
sumer protection, and pull back the shield that ERISA
provides them from legal liability. As an increasing
number of states are passing such laws, pressure will
continue to grow for Congress to set national consumer
protection standards, especially with regard to multi-
state plans that often object to having to comply with a
variety of state regulations.
STATE LEGISLATIVE ACTIVITY
The past few years have witnessed a heavy volume
of state managed care legislation, including consumer
protection measures. In 1997, 25 states enacted a wide
variety of laws requiring managed care plans to estab-
lish internal grievance procedures and comply with
external or independent review processes.12
While all 50 states require HMOs or managed care
plans to establish internal grievance and appeals pro-
cesses, the laws vary considerably. Differences include
which types of carriers must comply, whether a gradu-
ated review process is required, whether explicit time
frames are set forth, whether carriers must notify
consumers of appeal rights and assist them through the
process, whether expedited review is required, what
types of disputes qualify for review, what types of
qualification standards apply to reviewers, and whether
there are requirements for reporting the number and
type of internal grievances to regulators. In 1996, the
National Association of Insurance Commissioners
(NAIC) released the “Health Carrier Grievance Proce-
dure Model Act,” which requires two levels of internal
review, specific time periods in which to make deci-
sions, a 72-hour expedited review requirement for cases
involving medical urgency, and reporting requirements.
(States, of course, are free to copy, ignore, or modify
the NAIC model law as they please.)
A growing number of state legislatures have enacted
laws providing consumers with mechanisms for exter-
nal review of their complaints and appeals of managed
care plan denials.13 As of May 1998, about one-third of
the states gave enrollees in health plans access to a
review process after the carrier’s internal review is
completed. Again, there is a great deal of variety among
the state laws. The California and Ohio statutes, for
example, are limited to reviews of decisions on experi-
mental treatments. In some states, the degree to which
external review panels are independent of insurers is
debatable (for example, carriers may pick or help pick
members of review panels). Key characteristics of state
external review programs include the degree to which
the reviewers are independent, who pays for the re-
views, what types of denials qualify for review, whether
decisions are binding, who qualifies to provide the
service, and whether expedited decisions are required
based on medical urgency.
ERISA Preemption Issues
ERISA bars states from regulating private-sector
employer- and union-sponsored health plans but allows
states to regulate insurers serving the plans. About 40
percent of the 125 million Americans receiving health
coverage through ERISA plans are in self-insured
plans. Consequently, many, but not all, areas of con-
sumer protection differ depending on whether an
ERISA plan is insured or not. 
Which state functions are saved from preemption by
ERISA is often disputed in the courts. In the Metropol-
itan14 case, the Supreme Court determined that states
can require the inclusion of particular benefits, such as
mental health coverage, in insurance contracts that
cover ERISA participants. However, in Pilot Life,15 the
court decided that ERISA preempts access to traditional
state law remedies for ERISA participants in insured
plans as well as self-insured plans (that is, that state
remedies were not saved as a function of insurance
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regulation). So, far there is little case law to provide
guidance on whether state grievance and appeal laws
might be preempted, for either insured or self-insured
plans. While many believe such state laws may be
preempted for self-insured ERISA plans, it is less clear
whether they might be preempted for insured ERISA
plans. Texas and Missouri recently passed legislation
permitting managed care plan enrollees to sue the plans
when they are injured by a denial of coverage. The
Texas law, which is being challenged in court on
grounds that its state remedy provisions are preempted
by ERISA, also creates independent review organiza-
tions to which managed care enrollees can appeal
disputes over coverage.
Even if state grievance and appeal laws might be
preempted, carriers serving ERISA plans often adhere
to them in actual practice. The American Association
of Health Plans, which represents managed care plans,
is on record stating that nearly all HMO coverage
offered to employees is governed by state grievance
and appeal requirements.16 
GAO’s HMO SURVEY
In a recent report surveying policies in 38 HMOs in
five states, the U.S. General Accounting Office (GAO)
identified 11 features (falling into three categories)
considered important to a complaint and appeal system by
consumer, regulatory, and industry groups that agency
staff interviewed.17 Under the category of “timeliness,”
the GAO identified the following as key features:
 Explicit time periods for grievances and appeals.
 Expedited review.
Under the category of “integrity of the decision-making
process,” key elements identified were
 A two-level appeal process.
 Member attendance being permitted at one appeal
hearing.
 Appeal decisions being made by medical profession-
als with appropriate expertise.
 Appeal decisions being made by individuals not
involved in previous denials.
Under the category of “effective communication,” the
key elements were
 Written information being provided, in an under-
standable way, about how to register a complaint or
appeal.
 Acceptance of oral complaints.
 Acceptance of oral appeals.
 Appeal rights being included in notice of denial of
care or payment of a service.
 Written notice of appeal denials, including further
appeal rights.
The GAO reported that most of the 38 HMOs that
it contacted had incorporated most of the 11 key
elements in their policies. (The GAO study did not
determine the extent to which the HMOs actually
implemented the policies reported.) The investigators
attributed much of the uniformity they found to the
influence of the National Committee for Quality
Assurance (NCQA). Almost two-thirds of the plans in
the study had been surveyed by NCQA for accredita-
tion. However, more than half of the plans did not
feature two recommended elements: appeals decisions
being made by individuals not involved in previous
denials and acceptance of oral appeals.
There was considerable variation among the HMOs
in the characteristics of many key elements. For exam-
ple, time periods for first-level appeals varied from 10
days to 75 days and for second-level appeals from 10
days to two months. One HMO did not have explicit
time periods. Thirty-four of 36 HMOs reporting said
they used expedited appeal processes in cases where a
patient’s health might be jeopardized, but the length of
time for resolution of such appeals varied. The most
common time period for expedited appeals was 72
hours. Two HMOs called for resolution within 24 hours
and two others allowed for up to seven days. 
The GAO reported that independent external review
of plan decisions was considered particularly important
by consumer advocates but was not included as an
element critical to complaint and appeal systems by
regulatory or industry groups.
“EXTERNAL” REVIEW: TWO MODELS
Medicare Appeals
As noted above, many policymakers are looking to
the Medicare program for guidance on how to handle
“external, independent” appeals. The Medicare appeals
system is highly developed and has handled more cases
than state appeals systems. However, when considering
what to borrow from it for transplantation to the private
sector, it is important for policymakers to note that,
while the Medicare program offers an appeal function
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independent of managed care plans serving beneficia-
ries, the review is not external to the plan administrator
(the Health Care Financing Administration, which runs
the Medicare program). With regard to the relationship
between the plan sponsor and the consumer, the exter-
nal appeal remains an internal review function.18
In the Medicare risk program, there are two mutually
exclusive types of procedures for resolving enrollee
complaints: (a) the plan-internal “grievance” procedure
(from which decisions cannot be appealed outside the
managed care plan) and (b) Medicare’s appeals proce-
dure. Disputes about “initial determinations” by the
plan, which primarily concern denials of service or
payment, are resolved through the appeals procedure.
Complaints about matters such as waiting times, physi-
cian demeanor and behavior, and adequacy of facilities
are considered grievances.
There are five steps available to beneficiaries in the
Medicare appeals process:
 Initial determination by the managed care plan.
 A two-step reconsideration in which the plan re-
views its initial determination and then the Health
Care Financing Administration (HCFA) reviews the
case if the plan decision is partially or fully against
the beneficiary (this step involves independent
review by Medicare’s reconsideration contractor,
described below).
 A hearing by an administrative law judge, if at least
$100 is at issue.
 Review by the Appeals Council of the Social Secu-
rity Administration.
 Judicial review, if at least $1,000 is at issue.
Health plans contracting with HCFA normally have
up to 60 days to issue an initial determination notice. A
Medicare enrollee or his or her representative may
request an expedited organization determination if the
enrollee or representative believes the enrollee’s health,
life, or ability to regain maximum function may be
jeopardized by the standard 60-day process. If an
enrollee or representative makes the request, the plan
must decide whether the case qualifies for expedited
processing. If a physician makes the request, the
process must be expedited, that is, decided in 72 hours
or less as medically necessary or appropriate.
If a decision is unfavorable to an enrollee, the plan
must inform the enrollee of his or her appeal rights.
Plans normally have 60 days to make a reconsideration
recommendation. Again, the process can be expedited
at this stage on the same grounds as before. If the plan
does not completely reverse its initial decision, it must
forward the case to HCFA’s reconsideration contractor,
which is the Center for Health Dispute Resolution
(CHDR). The HCFA contractor normally decides cases
within 30 working days and is required to decide
expedited appeals within 10 working days. Expedited
processes are not available beyond this point in the
appeals system.
Any party to the reconsideration who is dissatisfied
with the reconsideration determination has a right to a
hearing before an administrative law judge (ALJ)of the
Social Security Administration if the dispute involves at
least $100. The risk contractor is not considered a party
to the reconsideration and thus does not have a right to
a hearing. Any party dissatisfied with the hearing
decision, including the managed care plan, may request
the Appeals Council of the Social Security Administra-
tion to review to judge’s decision or dismissal. Finally,
if the amount in controversy is at least $1,000, the case
may be appealed to a federal district court.19
Center for Health Dispute Resolution
Medicare’s only reconsideration contractor for
managed care for the past nine years, CHDR currently
reviews about 1,000 beneficiary appeals each month.
Located in the Rochester, New York, area, the organi-
zation also acts as an external reviewer for three state
programs and contracts with ERISA plans and HMOs.20
CHDR has about 25 full-time staff, most of them
attorneys, some also holding clinical degrees. There is
one “physician/attorney” and several “nurse/attorneys.”
CHDR’s services cost the Medicare program about four
cents per managed care enrollee per month. The total
value of services in dispute in 1996 came to about 32
cents per member per month. Roughly two-thirds of
appeals are decided in favor of plans.
In recent testimony before the House Ways and
Means Committee’s health subcommittee, CHDR
president David Richardson outlined four positive
features of Medicare’s managed care appeal model:
 All denial disputes are eligible for review, not just
those involving denials based on “medical neces-
sity.”
 The appeals process is linked to the evolution of
coverage policy.
 Appeal rights are widely publicized.
 Disputes of plan denial are automatically referred to
independent review performed by a multi-disciplin-
ary team, including physicians.
 8
 
According to Richardson, Medicare beneficiaries
can appeal a broader variety of plan coverage denials
than under the NAIC model and most state programs.
More than half of Medicare appeals arise due to dis-
putes that do not include issues of medical necessity.
These cases may involve, for example, disputes over
coverage, appeal procedures that the beneficiary failed
to follow, or use of out-of-network providers. While
CHDR upholds most coverage denials, it is inevitable
that errors of execution occur in large managed care
organizations and external review can provide feedback
to help plans correct mistakes, Richardson testified.
Despite Medicare’s relatively wide definition of
appealable denials, only 1 to 2 per 1,000 enrollees a
year seek to use the external appeals system. In 1997,
about 6 percent21 of those whose cases were reviewed
by CHDR later sought a hearing before an administra-
tive law judge. Less than 10 percent of the ALJ hear-
ings generated requests for a review by the Appeals
Council. Only a very few cases have gone on to court
over the years.
Where questions of medical necessity arise, CHDR
refers cases to a physician, dentist, or chiropractor for
evaluation. Most of these medical professionals practice
in the Rochester area. One reason for using local
providers is the need to give them enough volume for
the center to maintain relationships and quality of
service, according to Richardson. The center employs
a number of physicians at the Harvard School of Public
Health, including one who assists in recruiting physi-
cians for unusual cases and rare diseases.
Data gleaned from the appeals program have helped
Medicare develop coverage policy. According to
Richardson, CHDR data on denials of emergency room
care helped lead to development of the “prudent lay
person” standard for determining coverable emergency
room episodes. While such linkage remains an impor-
tant goal, it would be harder for an appeals process to
help inform the evolution of coverage policy in the
private sector. Instead of one underlying plan structure
serving the entire country as in Medicare, the 2.5
million health plans offered under ERISA come in a
great variety of plan designs and coverage packages.
Still, an argument might be made that external review
could be useful in this regard to large employer plans,
insurers, or health purchasing cooperatives.
CHDR handles about 300 expedited cases a month,
with an average time of resolution of four days. Prob-
lems sometimes arise, however, because both the
HMOs and CHDR experience delays in obtaining
medical records. (CHDR must obtain medical records
by overnight mail due to confidentiality concerns.)
Sometimes, in an expedited case, CHDR finds itself in
the awkward position of having to obtain medical
information that should have been collected when the
dispute was at the plan level (where the case also was
expedited), thereby expending more resources than it
would like and slowing down resolution of the case,
according to Richardson.
Florida’s Appeal Panel
In Florida, HMO subscribers who have exhausted an
HMO’s internal appeal procedure may appeal to a panel
made up of representatives from the state’s department of
insurance and its Agency for Health Care Administration
(AHCA). Created in 1985, the “Statewide Provider and
Subscriber Assistance Panel” received 75 to 100 appeals
a year from 1993 to 1997, with about 60 percent of the
decisions favoring consumers. Disputes involved quality
of and access to care, emergency services, unauthorized
services, and services deemed not medically necessary.22
One recent case, for example, involved a woman who had
been denied coverage for reconstructive surgery of one
breast, which had been removed as a preventive measure,
while the plan had approved reconstructive surgery for
the other breast, which had been removed after actually
developing cancer (the plan had approved removal of
both breasts). The appeals panel ordered that the plan
cover reconstructive surgery for both breasts and the
HMO complied.
The Florida appeal panel is just one part of a contin-
uum of mechanisms designed to help HMO members
resolve disputes over coverage and other grievances with
managed care plans. The Commercial Compliance Unit
within AHCA’s Bureau of Managed Care, which admin-
isters the panel, also staffs a statewide HMO hotline. The
hotline receives about 5,000 calls from consumers each
month. Most disputes of denied requests for urgently
needed medical care do not reach the appeal level but
rather are resolved between plans and consumers infor-
mally, with assistance of state hotline personnel, or within
HMOs’ internal grievance process. The vast majority of
cases that reach the external appeal stage involve payment
issues, not denials of medical care, according to Ree
Sailors, who has managed the Commercial Compliance
Unit for the past several years
Under Florida law, HMOs must resolve non-urgent
grievances within 60 days and urgent cases within 72
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hours. With regard to cases moving on either internal-
grievance time track, at a second stage of consideration
HMOs are required to make available review panels
comprising physicians who did not participate in the
original denials. Once the grievance process is com-
pleted, unresolved cases can be appealed to the state-
wide review panel. The panel makes decisions on three
time tracks: within 120 days for routine cases; 45 days
for urgent cases; and 24 hours for emergency cases.
After coming to a decision, the panel makes a recom-
mendation to the agency with appropriate jurisdiction.
The insurance department has jurisdiction over payment
issues, while quality of medical care issues come under
AHCA’s jurisdiction. Florida has a much stronger law
overseeing the quality of managed care than most states,
according to Sailors. If the agency with appropriate
jurisdiction concurs with the panel’s decision (it almost
always does because staff from both agencies are
members of the panel), it issues a regulatory order to the
HMO. In all but five cases, HMOs have complied with
such orders.
There are many gaps in the types of cases that the
appeal panel may hear, some caused by ERISA preemp-
tion of state law, according to Sailors. The panel faces a
very difficult situation in deciding whether to proceed
when a quality-of-care issue involves a person covered
by a self-insured employer contracting with an HMO,
she added. According to a Florida insurance regulator,
the appeals panel does not take cases from self-insured
ERISA plans. Medicaid cases can also fall outside the
panel’s jurisdiction. If a Medicare case involves a
quality of care issue that could have a systemic impact,
the panel may accept it, but Medicare cases involving
coverage issues are directed to the Medicare appeals
process, Sailors said.
THE FORUM SESSION
The meeting will begin with three short presenta-
tions to be followed by an open discussion. Geraldine
Dallek, a project director at Georgetown University’s
Institute for Health Care Research and Policy, will
describe key aspects of external review requirements
enacted by the states. Pamela Poulin, assistant general
counsel in the Office of General Counsel of Florida’s
Agency for Health Care Administration, will explain
how Florida’s external appeals panel works. David A.
Richardson, Jr., president of the Center for Health
Dispute Resolution will describe Medicare’s appeals
system, including the external appeals function pro-
vided by his organization.
Issue Questions
Issues to be addressed include the following:
 How would an external appeal requirement enacted
by Congress fit into the continuum of consumer
protections available to people in ERISA health
plans? How would it coordinate with DOL’s upcom-
ing revisions of the ERISA claims process, for
example? How would access to an external appeals
process be enforced?
 What roles should the states play in determining
grievance and appeal procedures for managed care
plans and insurers serving ERISA plans? Could
states build on federal external appeals standards,
should they be enacted? What would the states’ role
be in enforcing standards?
 What substantive lessons can be learned from the
experiences of the Medicare program and states
such as Florida about operating an external review
program? What are the important differences be-
tween these programs? To what degree might these
systems be replicated in the ERISA world?
 How should one define “external” when designing
an external review system for ERISA plans?
 What are the key elements of an external, independ-
ent system of reviewing health plan denials? For
example, would key elements include
– the kind of entities whose decisions would be
subject to appeal,
– the types of disputes that could be appealed,
– timeliness of the process (for example, specific
time frames and an expedited feature in case of
medical urgency),
– qualifications of reviewers,
– the integrity of the process (for example, who
chooses reviewers),
– access to the process (for example, cost to the
consumer, information about appeal rights,
rigidity of appeal process, whether appeals are
automatic or must be requested), and 
– standards applied in making review decisions (for
example, for medical necessity issues, are cost/
benefit considerations taken into account)?
 In what ways might an external appeals process help
the evolution of coverage policy in the private
sector? How can consistency be assured?
 10
 
1. A provider of external review services reviewing this
paper noted that, while external review can be viewed as a
“consumer protection,” it also can help plan sponsors in many
ways, such as in determining the quality of managed care they
are purchasing. 
2. ERISA, Sec. 503 (2).
3. 29 C.F.R. 2560.503-1.
4. Patricia Butler and Karl Polzer, “Private-Sector Health
Coverage: Variation in Consumer Protections under ERISA
and State Law,” National Health Policy Forum, Washington,
D.C., June 1996, 49.
5. Patricia Butler, “Managed Care Plan Liability: An
Analysis of Texas and Missouri Legislation,” prepared for the
Henry J. Kaiser Family Foundation, Menlo Park, California,
November 1997, 20.
6. See Phyllis Borzi, “ERISA Preemption and Managed
Care: Current Issues of Importance to Employers and Provid-
ers,” ALI-ABA Video Law Review: Fiduciary Responsibility
Issues under ERISA Qualified Pension and 401(k) Plans,
ESOPs, and Managed Care Plans, June 5, 1997.
7. 965 F. 2d 1321 (5th Cir. 1992).
8. President’s Advisory Commission on Consumer Protec-
tion and Quality in the Health Care Industry, “Quality First:
Better Health Care for All Americans: Final Report to the
President of the United States” (Washington, D.C.: U.S.
Government Printing Office, 1998), A-61.
9. Federal Register, 62 (September 8, 1997), no. 173:
47262.
10. Testimony of Marc I. Machiz, associate solicitor for plan
benefits security, U.S. Department of Labor, before the
Subcommittee on Roles and Responsibilities of Public/
Private Purchasers and Quality Oversight Organizations of
the Commission on Consumer Protection and Quality in the
Health Care Industry, February 25, 1998, 8.
11. Butler and Polzer, “Private-Sector Health Coverage,” 47.
12. Molly Stauffer, “Consumer Grievance Procedures:
Internal and External Appeals,” Health Policy Tracking
Service, National Conference of State Legislatures, Washing-
ton, D.C., May 12, 1998.
13. Stauffer, “Consumer Grievance Procedures.”
14. Metropolitan Life Insurance Co. v. Massachusetts, 471
U.S. 724 (1985).
15. Pilot Life Insurance Co. v. Dedeaux, 481 U.S. 41 (1987).
16. General Accounting Office (GAO), “HMO Complaints
and Appeals: Most Key Procedures in Place, but Others
Valued by Consumers Largely Absent,” GAO/HEHS-98-119,
May 1998, 5.
17. GAO, “HMO Complaints and Appeals,” 7.
18. In the Medicare appeals process, review by an administra-
tive law judge that may follow the external appeal is inde-
pendent of the Medicare program.
19. Medicare beneficiaries cannot sue the federal government
for remedies but can sue health plans in state courts under
either tort or contract law to claim compensation for losses
and punitive damages. Source: President’s Advisory Commis-
sion, “Quality First,” 162.
20. Testimony of David A. Richardson, Jr., president of the
Center for Dispute Resolution, before the U.S. House of
Representatives Committee on Ways and Means Subcommit-
tee on Health, April 23, 1998. Information about CHDR was
taken from a variety of sources, including the testimony cited
above and an interview with Richardson by the author.
21. A total of 528 people.
22. Information about the Florida appeals program was
gathered by the author from interviews with Ree Sailors, of
the state’s Agency for Health Care Administration, and
officials in the state insurance department. See also GAO,
“HMO Complaints and Appeals.”
 Given the proliferation of laws in this area, what
type of market might develop for external appeals
services? How large might demand be for appeals?
How competitive can this “market” be, given its
potential size?
 What type of accreditation should be required of
reviewers and review organizations? Who should
perform this function?
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